The authors of this review, published in the December 2022 issue, requested to clarify the following sentences:
“This is an interesting finding as it matches the finding of type I IFN enrichment in IPF both in monocytes [50] and in a subset of macrophages (SPP1+ macrophages) [51]. Both of these findings have been associated with the extent of fibrosis in the lungs of IPF patients.”
The study cited as reference [51] reported that upregulation of type 1 IFN genes in SPP1+ macrophages was seen in systemic sclerosis associated interstitial lung disease patients, not IPF patients. As a result, this section of text has been corrected to read:
“This is an interesting finding as it matches the finding of type I IFN enrichment in IPF in monocytes [50] and in a subset of macrophages (SPP1+ macrophages) in systemic sclerosis associated interstitial lung disease patients [51]. Levels of monocytes were associated with extent of fibrosis in the lungs of IPF patients [50].”
The article has been corrected and republished online.
- Copyright ©ERS 2023
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org